We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Reprogrammed Immune Cells Hunt Down and Destroy Cancer Cells

By HospiMedica International staff writers
Posted on 15 Aug 2023
Print article
Image: The body’s own immune cells can be programmed to carry therapeutics to places where treatment normally cannot reach (Photo courtesy of Freepik)
Image: The body’s own immune cells can be programmed to carry therapeutics to places where treatment normally cannot reach (Photo courtesy of Freepik)

The human body wards off illnesses by employing immune cells to enter and destroy disease cells. However, certain dangerous cells, including some solid tumors, operate covertly, evading the body's regular immune system. Now, a breakthrough in targeted cell therapy makes it possible to reprogram a patient's own immune cells, giving them the ability to hunt down and destroy these cancer cells.

Edity Therapeutics (Rehovot, Israel) is reprogramming immune cells to serve as a delivery vehicle. These cells will contain therapeutic payloads, primed to locate and destroy not just cancer cells but also a range of diseases that currently lack a cure. The reprogramming immune cells, known as ED 007, will be trained by Edity to recognize solid tumors that generally elude recognition by the body's own immune system, enabling their unrestrained growth and metastasis. ED 007 will promote inflammation within these tumors, triggering the body's inherent immune response to destroy the cancerous cells. Given that the retrained cells are derived from the patient's own body, the risk of rejection and autotoxicity is likely to be minimal.

The concept of reprogramming a patient's own cells to fight cancer has demonstrated success in individuals with blood cancer. Edity is poised to take the next leap, aiming to utilize these retrained immune cells, including ED 007, to target solid tumors that create treatment challenges. Edity employs a straightforward yet potent process: Patients provide a blood sample from which specialized white blood cells known as T cells are extracted. These cells are then engineered in a laboratory setting to carry the necessary medication for treatment. After a brief incubation period, the engineered cells are reintroduced into the patient's body. Loaded with medication, the immune cells navigate directly to the patient’s damaged cells and start repairing the diseased tissues.

“Science allows us to treat any disease in a test tube but there are still many diseases with no cure,” Dr. Michal Golan-Mashiach, Edity’s CEO and Founder told The Times of Israel. “Edity’s technology will bring new treatment options to previously incurable diseases, offering new medicines to patients and their families.”

Related Links:
Edity Therapeutics 

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
12-Channel ECG
CM1200B
New
Standing Sling
Sara Flex
New
Infant Phototherapy Unit
TRP100

Print article

Channels

Surgical Techniques

view channel
Image: By optimizing the material design during 3D printing, the enhancement of the bioactivity of porous tantalum (pTa) bone implants can be better achieved (Photo courtesy of Manyuan Wu, Mingchun Zhao, Ying Cai)

3D-Printed Porous Tantalum an Emerging Material for New Generation of Orthopedic Implants

Bones are the hard organs that form the endoskeleton of vertebrates, featuring a complex inner and outer structure that allows them to maintain hardness while minimizing weight. Their roles include facilitating... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.